Iteris' stockholders approve merger agreement with Almaviva
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 23 2024
0mins
Merger Approval: Iteris stockholders approved the merger agreement with Almaviva, where Almaviva will acquire Iteris for $7.20 per share, totaling approximately $335 million in equity value.
Transaction Timeline: The merger is expected to close around November 1, pending customary closing conditions, after which Iteris common stock will be delisted from public markets.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
